A woman from WA has become the second Australian to suffer a rare blood clotting condition after receiving the AstraZeneca vaccine.
The woman aged in her 40s is in a stable condition in hospital after being diagnosed with a case of “thrombosis with thrombocytopenia”.
The Therapeutic Goods Administration (TGA) issued a statement on Tuesday and said the case is "likely to be linked to the vaccination".
"The panel concluded that the case is similar to cases seen in Europe and the United Kingdom of a rare clotting disorder, referred to as 'thrombosis with thrombocytopenia syndrome' (TTS)."
There have been about 700,000 doses of AstraZeneca vaccines administered in Australia to date.
The second case now means one in 350,000 AstraZeneca vaccinations administered in the country have potential ties to blood clots.
"The TGA is carefully reviewing all Australian reports of blood clots following the AstraZeneca vaccine," the statement read.
People who have received the vaccine should seek immediate medical attention if they develop symptoms such as a severe or persistent headache, blurred vision, shortness of breath, chest pain, leg swelling or unusual skin bruising and/or pinpoint round spots beyond the site of injection.
Daniel Bandy appointed CEO of Peel Thunder Football Club
Dwellingup comes alive ahead of Dwellingup 100 and Mighty Jarrah Trail Run event
Man charged, others on the run after Mandurah Forum knife incident
Man critically injured in North Dandalup crash
Kwinana Recquatic's swim school recognised nationally
Rockingham Police: Locals advised not to approach wanted man
Concerns for missing girl
Peel Thunder cruise into 2026 WAFL grand final
Two teens cautioned, one charged over brutal Falcon attack